News
French drugmaker Sanofi SA (NASDAQ:SNY) on Monday said it is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure ...
The green light in the US is the first worldwide for Enflonsia ( clesrovimab) and makes the long-acting antibody the first ...
Zacks.com on MSN9h
Slowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?Merck's Gardasil sales decline due to weak demand trends in China, with new launches expected to offset the downside.
One day before the potential FDA approval of a rival respiratory syncytial virus (RSV) monoclonal antibody from Merck & Co., ...
Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is shipping Beyfortus (nirsevimab) starting in early ...
French pharma major Sanofi (Euronext: SAN) has started early global shipments of its monoclonal antibody Beyfortus ...
Sanofi has tripled Beyfortus production and doubled manufacturing sites since its 2023 launch. Get the Strategy to Trade Pre-Fed Setups and Post-Fed Swings—Live With Chris Capre on Wednesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback